What Loceryl 5% treats: main uses and benefits

Loceryl 5% is a medicated nail lacquer containing the active ingredient amorolfine. It is specifically formulated to address fungal infections affecting the nails, a condition medically known as onychomycosis.

Main Uses

The primary use of Loceryl 5% is the treatment of mild to moderate fungal nail infections. These infections typically manifest in the following ways:

• Distal and Lateral Subungual Onychomycosis: This is the most common form, where the fungus enters the nail bed and the underside of the nail plate, usually starting at the edge or sides of the nail.
• Superficial White Onychomycosis: A less common form where the infection appears as white, powdery patches on the surface of the nail plate.

The lacquer is indicated for cases where the infection is limited to the upper half or sides of the nail and does not involve the nail root (matrix).

Benefits and Mechanism of Action

Loceryl 5% provides several therapeutic benefits through its antifungal properties:

• Broad-Spectrum Antifungal Activity: Amorolfine is effective against a wide range of fungi that cause nail infections, including dermatophytes, yeasts, and molds.
• Targeted Delivery: As a lacquer, the medication is applied directly to the affected nail. Once the solvent evaporates, it leaves a highly concentrated film of amorolfine on the nail plate.
• Deep Penetration: The formulation is designed to penetrate through the hard keratin of the nail plate into the nail bed, reaching the site of the infection where standard topical creams often cannot reach effectively.
• Sustained Action: After application, the active ingredient remains present in the nail at therapeutic concentrations for an extended period, allowing for infrequent application while maintaining its antifungal effect.

By inhibiting the growth of the fungus and eventually eliminating it, the treatment supports the gradual regrowth of a healthy, non-infected nail.

Eligibility Map: Who Can and Cannot Use Loceryl 5%

Category	Official Regulatory Status
Populations for whom use is allowed	Adults (18 years and older) for the treatment of fungal nail infections.
Populations for whom use is contraindicated	Patients with known hypersensitivity or allergy to the active substance amorolfine or any excipients in the nail lacquer.
Age-related eligibility rules	Pediatric use is not recommended for children and adolescents (under 18 years) due to a lack of clinical experience in this age group. Use in older adults is permitted with no specific dosage adjustments required.
Pregnancy and lactation eligibility	Use should be avoided during both pregnancy and lactation due to limited human data and experience.
Condition-specific eligibility rules	Use requires special consideration and physician consultation for patients with underlying conditions such as diabetes mellitus, peripheral circulatory disorders, or immune system disorders.

---

Connection to the overall eligibility profile:

Regulatory documents establish that only adults are officially permitted to use Loceryl 5% under standard conditions, with the primary absolute exclusion being a documented hypersensitivity to the ingredients. Use in pediatric populations, as well as during pregnancy and lactation, is formally not recommended due to insufficient clinical data. Specific systemic conditions or severe nail damage prompt a restriction requiring professional consultation.

Interaction Map: Interactions with other medicines and products — official regulatory information for Loceryl 5%

Interaction scope

Property	Description
Medicinal product categories with documented interactions	None.
Specific interacting medicines (if explicitly listed)	None.
Mechanistic basis of interactions (only if stated in label)	None documented. Very low systemic absorption precludes clinically relevant systemic pharmacokinetic or pharmacodynamic interactions.
Timing-based interaction rules (if applicable)	Mandatory 10-minute separation required between the application of the medicated lacquer and any subsequent application of cosmetic nail varnish.
Population-specific interaction notes (if applicable)	None documented.
Interaction-related restrictions	Use of artificial nails is strictly restricted during the course of treatment. The use of impermeable gloves is required when handling organic solvents (e.g., paint thinners, white spirit) to prevent lacquer removal.

---

Interaction classifications (high-level)

Property	Description
Interaction severity classification (as defined in official documents)	Not applicable for systemic drug-drug interactions; classified as restrictions and timing requirements for non-medicinal products/substances.
Regulatory basis (EMA / FDA / etc.)	Primary basis is the European Summary of Product Characteristics (SmPC) / regulatory datasheets, reflecting negligible systemic exposure.
Interaction-context constraints (as defined in official documents)	The primary constraints relate to the physical integrity of the medicated film on the nail surface.

---

Resulting interaction structure

Official interaction statements:

• The product has no known interactions with other systemic medicines due to the very low systemic absorption of Amorolfine, and no interaction studies have been performed to evaluate this risk.
• A time separation rule requires that cosmetic nail varnish must be applied at least 10 minutes after the Loceryl 5% application.
• The regulatory label prohibits the co-use of artificial nails during the treatment period.
• To prevent removal of the medicated lacquer, impermeable gloves must be used during exposure to organic solvents such as thinners or white spirit.

Connection to the overall interaction profile: The regulatory interaction profile is defined by the product's topical application, establishing the primary interaction concern as local rather than systemic. Official documentation explicitly addresses this via statements confirming the absence of known drug–drug interactions. The profile, therefore, structures its mandatory constraints around maintaining the integrity of the medicated film against non-medicinal substances, enforcing strict prohibitions and timing rules.

Dual Blockade of Fungal Sterol Synthesis

The mechanism of Amorolfine is defined by its ability to inhibit two fungal enzymes, Delta^14-sterol reductase and Delta^7-Delta^8-isomerase, which are required steps in the ergosterol biosynthesis pathway. This dual action prevents the synthesis of Ergosterol, the principal structural sterol of the fungal cell membrane.

Catastrophic Fungal Cell Disruption

By blocking Ergosterol synthesis, the mechanism forces the accumulation of precursor sterols, such as Ignosterol, within the cell membrane. This compromises the membrane's structural integrity and controlled permeability , leading to the irreversible leakage of cellular contents and the physiological action of fungicidal cell death.

Mechanism Constraint by Metabolic State

The drug's mechanism is maximally effective only when the fungal organism is actively synthesizing sterols, making it a metabolism-dependent action. Its physiological effect is consequently reduced against fungal cells that are in a dormant state, such as spores, as the mechanism requires the fungus to be in a growth phase.

Loceryl 5% (amorolfine) medicated nail lacquer is typically applied to the affected nails once or twice a week, or as directed by a healthcare provider. Consistent and uninterrupted application is essential for effective treatment, which can take approximately six months for fingernails and nine to twelve months for toenails until the healthy nail has grown back.

Application Steps

Step	Action	Key Precaution
1. File	File the entire surface of the affected nail(s) with a new nail file to remove diseased areas and roughen the surface.	Never use files from an infected nail on healthy nails or share them, to prevent spreading the infection.
2. Clean	Wipe the nail surface with a cleaning swab to remove debris and degrease the nail. Use a separate swab for each affected nail or dispose of the swab after cleaning all affected nails.
3. Apply	Dip the reusable applicator into the lacquer. Apply the lacquer evenly over the entire surface of the infected nail. Repeat for each affected nail.	Avoid applying the lacquer to the skin around the nail, eyes, ears, or mucous membranes.
4. Dry	Allow the treated nail(s) to dry for approximately three to five minutes. Cosmetic nail polish, if used, should only be applied after at least ten minutes.
5. Cleanup	Clean the applicator and the neck of the bottle thoroughly using the same cleaning swab, then close the bottle tightly.

Before subsequent applications, always remove the old lacquer and any nail polish using the provided swab or commercial remover, and file the nail again as needed. Once dry, the lacquer is water-resistant. However, wear impermeable gloves when handling organic solvents like paint thinners to protect the lacquer coat.

Research Evidence / Overview of studies for Loceryl 5%

Evidence for Use in Mild to Moderately Severe Fungal Nail Infection (Onychomycosis)

Research on the Amorolfine nail lacquer as a standalone treatment primarily involves Randomized Controlled Trials (RCTs). These studies were designed to compare the medicine against either a non-medicated lacquer or another existing topical antifungal. The main goals were to measure two objective outcomes: mycological clearance (laboratory confirmation of fungal absence) and clinical improvement (measurement of the visually clear nail area).

Findings describe patterns observed in the trials related to patterns of fungal clearance and visual improvement. Because the nail grows slowly, the reported outcomes were observed over an extended duration, typically 12 to 18 months. Furthermore, achieving a complete clearance endpoint—which requires both the confirmation of fungal absence and the nail to be fully visually clear—was observed to have mixed patterns across various studies.

Evidence for Use in Severe Fungal Nail Infection

Research examined the use of the nail lacquer in combination with an oral antifungal tablet in study populations with more extensive or severe infections. These studies were designed as RCTs comparing the combination approach against using the oral tablet by itself. Studies monitored whether this combination approach was related to outcome patterns when comparing the topical lacquer alongside a systemic tablet versus the tablet used as a monotherapy.

For severe cases, when the lacquer was used in combination with an oral tablet, the overall evidence level for the combination setting is described as high. However, the specific contribution of the topical lacquer alone to the final outcome remains challenging to isolate.

Long-Term Studies and Follow-Up Periods

Research has explored the long-term question of whether the infection comes back after a successful treatment conclusion. Data show patterns related to a potential delay in the reappearance of the fungus for those who continued application. However, the evidence is limited for long-term outcomes and the certainty remains low. Research has not fully established the duration of continued application needed to potentially influence relapse rates.

Key Studies & References

1. Combination topical and systemic therapy for onychomycosis: a systematic review and meta-analysis
2. Public Assessment Report (PAR) on Amorolfine

Common questions about Loceryl 5% (FAQ)

Q: What kind of nail fungus is Loceryl 5% approved to treat?

A: Official product information indicates that Loceryl 5% is used for fungal nail infections, or onychomycosis. The medicine's indication covers infections caused by dermatophytes, yeasts, and moulds, as stated in regulatory documents.

Q: What should the nail generally look like when the treatment is considered complete?

A: According to official documents, the goal of treatment is for the infection to have completely cleared and a healthy, new nail to have fully grown back. Since nails grow slowly, this outcome is the visual marker that treatment is finished.

Q: Does the medicine also treat the skin around the infected nail or just the nail itself?

A: Loceryl 5% is formulated specifically as a nail lacquer for topical use only on the infected nail plate. Regulatory warnings specify that the medicine should be kept away from the surrounding skin, eyes, ears, and mucous membranes. The intended application area is strictly the nail.

Q: Is nail thinning reported as a possible consequence of using Loceryl 5%?

A: Official regulatory documents report certain rare adverse effects related to the nail structure, such as discoloration, brittleness (onychorrhexis), or broken nails. However, the specific condition of nail thinning is not explicitly listed in the reported adverse effect classifications.

Q: Do you need a prescription to get Loceryl 5% in most countries?

A: The regulatory classification of Loceryl 5% varies by country. In many regions, this medicine is designated as a 'Pharmacy-only' product. This means that while a doctor's prescription may not be strictly required, the medicine is dispensed only by a pharmacist who provides necessary safety information.

Q: Can the application of Loceryl 5% affect the results of other medical tests?

A: Official regulatory documents note the medicine’s topical application and very low systemic absorption. Because of this, the active ingredient is not known to cause clinically relevant systemic interactions with other medicines.

Q: Is Loceryl 5% known to be available in different strengths?

A: According to the official regulatory composition documents, Loceryl medicated nail lacquer is authorized and officially available in one specific concentration. This standard strength is 5% w/v amorolfine.

Q: If an application of Loceryl 5% is missed, what is the general protocol?

A: Regulatory instructions describe a general protocol if an application is missed. If this occurs, the regulatory guidance is to resume the application schedule in the same way as before when the user remembers. Consistent treatment without interruption is described as essential for the full duration of therapy.

Q: How long can the Loceryl 5% bottle be kept after it has been opened?

A: Official regulatory documents stipulate a specific shelf life for the medicine after the packaging is opened. To maintain the product’s stability and effectiveness, the regulatory guidance indicates that the product should be kept and used within a period of 3 months after the bottle has been first opened.

Q: Are there any reported warnings about driving or operating machinery while using Loceryl 5%?

A: As a topical nail lacquer that acts locally on the nail, official product information has determined that the medicine has no relevant effect. Patients are not typically expected to have impaired judgment or physical ability related to driving or using machinery while using this medicine.

Q: Can I use Loceryl 5% if I have a history of skin conditions like eczema on my feet?

A: Official warnings note that patients who have underlying chronic conditions, such as diabetes or peripheral circulatory disorders, require special consideration. The regulatory information advises that patients with a history of chronic skin issues like eczema or psoriasis should seek consultation with a healthcare professional before commencing treatment.

Q: What kind of official safety classification does Loceryl 5% have?

A: Regulatory bodies classify this medicine based on its chemical and therapeutic properties. Amorolfine is officially classified as a topical antimycotic, which is a specialized type of antifungal agent. This classification establishes its role as a focused treatment applied directly to the site of the fungal infection.

Q: Can I wear shoes and socks immediately after applying the lacquer?

A: Official directions specify that the treated nail(s) should be allowed to dry for approximately three minutes after application. This drying period is the primary constraint. Regulatory documents do not provide a further specific instruction regarding the wearing of shoes or socks after the lacquer has dried.

Q: If the dried lacquer cracks or peels, does that means the treatment is no longer working?

A: Regulatory instructions emphasize the necessity of continuous, uninterrupted treatment for the full duration of the therapy. If the dried lacquer film cracks, peels, or is compromised, the regulatory guidance is that the old coat should be removed and a new coat applied to maintain the film’s integrity and consistent treatment.

Q: What is the maximum area of the nail that Loceryl 5% is intended to treat?

A: The medicine is generally indicated for mild fungal nail infections that do not involve the nail root (nail matrix). Regulatory documentation suggests that if the fungal infection affects more than two-thirds of the nail plate or involves multiple nails, systemic (oral) therapy may be considered and professional consultation is needed.

Storage and Disposal of Loceryl 5% Medicated Nail Lacquer

The storage and disposal requirements for Loceryl 5% (Amorolfine) are strictly defined by regulatory labeling to ensure stability and safety.

Storage Conditions

Requirement	Official Instruction
Temperature	Store below 30 °C.
Handling	Keep away from heat, naked flames, and ignition sources.
Container	Close the bottle tightly immediately after use to prevent evaporation.
Child Safety	Keep out of the sight and reach of children.

Disposal Instructions

Unused or expired medicine and waste material must be disposed of in accordance with local requirements. The product must not be disposed of via wastewater or household waste due to its formulation. A pharmacist should be consulted for proper disposal procedures.